BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 29434227)

  • 1. The NLRP3 Inflammasome May Contribute to Pathologic Neovascularization in the Advanced Stages of Diabetic Retinopathy.
    Chaurasia SS; Lim RR; Parikh BH; Wey YS; Tun BB; Wong TY; Luu CD; Agrawal R; Ghosh A; Mortellaro A; Rackoczy E; Mohan RR; Barathi VA
    Sci Rep; 2018 Feb; 8(1):2847. PubMed ID: 29434227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular analysis of blood-retinal barrier loss in the Akimba mouse, a model of advanced diabetic retinopathy.
    Wisniewska-Kruk J; Klaassen I; Vogels IM; Magno AL; Lai CM; Van Noorden CJ; Schlingemann RO; Rakoczy EP
    Exp Eye Res; 2014 May; 122():123-31. PubMed ID: 24703908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-cell transcriptome analysis of the Akimba mouse retina reveals cell-type-specific insights into the pathobiology of diabetic retinopathy.
    Van Hove I; De Groef L; Boeckx B; Modave E; Hu TT; Beets K; Etienne I; Van Bergen T; Lambrechts D; Moons L; Feyen JHM; Porcu M
    Diabetologia; 2020 Oct; 63(10):2235-2248. PubMed ID: 32734440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinal VEGF-A Overexpression Is Not Sufficient to Induce Lymphangiogenesis Regardless of VEGF-C Upregulation and Lyve1+ Macrophage Infiltration.
    Wada I; Nakao S; Yamaguchi M; Kaizu Y; Arima M; Sawa S; Sonoda KH
    Invest Ophthalmol Vis Sci; 2021 Oct; 62(13):17. PubMed ID: 34673901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NLRP3 inflammasome activation is associated with proliferative diabetic retinopathy.
    Loukovaara S; Piippo N; Kinnunen K; Hytti M; Kaarniranta K; Kauppinen A
    Acta Ophthalmol; 2017 Dec; 95(8):803-808. PubMed ID: 28271611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiography reveals novel features of the retinal vasculature in healthy and diabetic mice.
    McLenachan S; Magno AL; Ramos D; Catita J; McMenamin PG; Chen FK; Rakoczy EP; Ruberte J
    Exp Eye Res; 2015 Sep; 138():6-21. PubMed ID: 26122048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Akimba Proliferative Diabetic Retinopathy Model: Understanding Molecular Mechanism and Drug Screening for the Progression of Diabetic Retinopathy.
    Tun SBB; Barathi VA
    Methods Mol Biol; 2023; 2678():13-26. PubMed ID: 37326702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of clinical correlates of diabetic retinopathy in the Ins2Akita retina.
    McLenachan S; Chen X; McMenamin PG; Rakoczy EP
    Clin Exp Ophthalmol; 2013 Aug; 41(6):582-92. PubMed ID: 23433122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical Characterization of Connexin43 Expression in a Mouse Model of Diabetic Retinopathy and in Human Donor Retinas.
    Mugisho OO; Green CR; Zhang J; Binz N; Acosta ML; Rakoczy E; Rupenthal ID
    Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29186067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysregulation of trophic factors contributes to diabetic retinopathy in the Ins2
    Araújo RS; Silva MS; Santos DF; Silva GA
    Exp Eye Res; 2020 May; 194():108027. PubMed ID: 32259534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the TXNIP/NLRP3 inflammasome pathway contributes to inflammation in diabetic retinopathy: a novel inhibitory effect of minocycline.
    Chen W; Zhao M; Zhao S; Lu Q; Ni L; Zou C; Lu L; Xu X; Guan H; Zheng Z; Qiu Q
    Inflamm Res; 2017 Feb; 66(2):157-166. PubMed ID: 27785530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term lutein administration attenuates retinal inflammation and functional deficits in early diabetic retinopathy using the Ins2
    Wang W; Tam KC; Ng TC; Goit RK; Chan KLS; Lo ACY
    BMJ Open Diabetes Res Care; 2020 Jul; 8(1):. PubMed ID: 32665315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of integrin α5β1 ameliorates VEGF-induced retinal neovascularization and leakage by suppressing NLRP3 inflammasome signaling in a mouse model.
    Sui A; Zhong Y; Demetriades AM; Lu Q; Cai Y; Gao Y; Zhu Y; Shen X; Xie B
    Graefes Arch Clin Exp Ophthalmol; 2018 May; 256(5):951-961. PubMed ID: 29502235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Protective effect of ginsenoside Rg_1 aganist diabetic retinopathy by inhibiting NLRP3 inflammasome in type 2 diabetic mice].
    Li B; Zhang DC; Li XW; Dong XN; Li WP; Li WZ
    Zhongguo Zhong Yao Za Zhi; 2022 Jan; 47(2):476-483. PubMed ID: 35178992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a mouse model of hyperglycemia and retinal neovascularization.
    Rakoczy EP; Ali Rahman IS; Binz N; Li CR; Vagaja NN; de Pinho M; Lai CM
    Am J Pathol; 2010 Nov; 177(5):2659-70. PubMed ID: 20829433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fenofibrate ameliorates diabetic retinopathy by modulating Nrf2 signaling and NLRP3 inflammasome activation.
    Liu Q; Zhang F; Zhang X; Cheng R; Ma JX; Yi J; Li J
    Mol Cell Biochem; 2018 Aug; 445(1-2):105-115. PubMed ID: 29264825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of NLRP3 Inflammasome Activation in the Onset of Diabetic Retinopathy.
    Kuo CY; Maran JJ; Jamieson EG; Rupenthal ID; Murphy R; Mugisho OO
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The IL-23/IL-17 axis promotes the formation of retinal neovascularization by activating the NLRP3 inflammasome in macrophages in an experimental retinopathy mouse model.
    Sui A; Chen X; Yao Y; Yao Y; Shen X; Zhu Y; Xie B
    Immunology; 2021 Dec; 164(4):803-816. PubMed ID: 34396536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resolvin D1 inhibits inflammatory response in STZ-induced diabetic retinopathy rats: Possible involvement of NLRP3 inflammasome and NF-κB signaling pathway.
    Yin Y; Chen F; Wang W; Wang H; Zhang X
    Mol Vis; 2017; 23():242-250. PubMed ID: 28465656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ASK1/p38‑mediated NLRP3 inflammasome signaling pathway contributes to aberrant retinal angiogenesis in diabetic retinopathy.
    Zou W; Luo S; Zhang Z; Cheng L; Huang X; Ding N; Pan Y; Wu Z
    Int J Mol Med; 2021 Feb; 47(2):732-740. PubMed ID: 33416127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.